Latest news

April 5, 2018

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

Read more
May 9, 2017

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Read more
March 7, 2017

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Read more
March 2, 2017

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Read more
August 30, 2016

Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests

Read more
July 13, 2016

Debiopharm acquires a majority holding in the Canadian start-up GenePOC

Read more
January 13, 2015

Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital

Read more
September 17, 2014

Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument

Read more
March 5, 2014

Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group™

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Innovation Fund, subscribe to our newsletter.